Cargando…

Serum CGRP in migraine patients using erenumab as preventive treatment

AIM: Serum levels of Calcitonin Gene-Related Peptide (CGRP)-like immunoreactivity (CGRP-LI) in migraine patients before and after starting treatment with erenumab were measured to evaluate the association with clinical treatment response. METHODS: Blood samples were collected from the cubital fossa...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vries Lentsch, Simone, Garrelds, Ingrid M., Danser, A. H. Jan, Terwindt, Gisela M., MaassenVanDenBrink, Antoinette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464612/ https://www.ncbi.nlm.nih.gov/pubmed/36089587 http://dx.doi.org/10.1186/s10194-022-01483-z

Ejemplares similares

The potential danger of blocking CGRP for treating migraine in CADASIL patients
por: de Boer, Irene, et al.
Publicado: (2020)

Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study
por: de Vries Lentsch, Simone, et al.
Publicado: (2021)

Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies: A Prospective Follow-up Study
por: de Vries Lentsch, Simone, et al.
Publicado: (2022)

Gender aspects of CGRP in migraine
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2017)

Blocking the CGRP Receptor: Differences across Human Vascular Beds
por: de Vries, Tessa, et al.
Publicado: (2023)

Measurements of 17β-estradiol levels in mice for migraine research
por: Chan, K, et al.
Publicado: (2013)

Methylation of Migraine-Related Genes in Different Tissues of the Rat
por: Labruijere, Sieneke, et al.
Publicado: (2014)

Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2018)

Endothelin-converting-enzyme 1 inhibition and CGRP receptor recycling in human coronary and middle meningeal arteries
por: Labruijere, S, et al.
Publicado: (2013)

Jealousy in women with migraine: a cross-sectional case-control study
por: van Casteren, Daphne S., et al.
Publicado: (2020)

Pain perception in women with menstrually-related migraine
por: Linstra, Katie M, et al.
Publicado: (2020)

Sex differences in prevalence of migraine trigger factors: A cross-sectional study
por: van Casteren, Daphne S, et al.
Publicado: (2020)

Influence of varying estrogen levels on trigeminal CGRP release in healthy women
por: Ibrahimi, K, et al.
Publicado: (2013)

Could erectile dysfunction be a side effect of CGRP inhibition? A case report
por: Al-Hassany, Linda, et al.
Publicado: (2021)

Comment on “A second trigeminal CGRP receptor: function and expression of the AMY1 receptor”
por: Haanes, Kristian Agmund, et al.
Publicado: (2016)

Validation of diagnostic ICHD-3 criteria for menstrual migraine
por: Verhagen, Iris E, et al.
Publicado: (2022)

Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study
por: Verhagen, Iris E., et al.
Publicado: (2021)

Headache medication and the COVID-19 pandemic
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2020)

Correction to: Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study
por: Verhagen, Iris E., et al.
Publicado: (2021)

E-diary use in clinical headache practice: A prospective observational study
por: van Casteren, Daphne S, et al.
Publicado: (2021)

Blocking CGRP in migraine patients – a review of pros and cons
por: Deen, Marie, et al.
Publicado: (2017)

17β-estradiol and methylation of migraine-related genes
por: Labruijere, S, et al.
Publicado: (2013)

Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary
por: van Casteren, Daphne S., et al.
Publicado: (2021)

Impact of age and sex on the efficacy of fremanezumab in patients with difficult-to-treat migraine: results of the randomized, placebo-controlled, phase 3b FOCUS study
por: MaassenVanDenBrink, Antoinette, et al.
Publicado: (2021)

Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus
por: Rivera-Mancilla, Eduardo, et al.
Publicado: (2021)

Vascular safety of erenumab for migraine prevention
por: Kudrow, David, et al.
Publicado: (2020)

Trigeminovascular calcitonin gene-related peptide function in Cacna1a R192Q-mutated knock-in mice
por: Chan, Kayi Y, et al.
Publicado: (2017)

Effect of lockdown during COVID-19 on migraine: A longitudinal cohort study
por: Verhagen, Iris E, et al.
Publicado: (2021)

CGRP, adrenomedullin and adrenomedullin 2 display endogenous GPCR agonist bias in primary human cardiovascular cells
por: Clark, Ashley J., et al.
Publicado: (2021)

Revisiting dose-finding of monoclonal antibodies in migraine
por: Al-Hassany, Linda, et al.
Publicado: (2023)

Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system
por: Labastida-Ramírez, Alejandro, et al.
Publicado: (2020)

Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds
por: Grände, Gustaf, et al.
Publicado: (2014)

CGRP Inhibitors and Oxidative Stress Biomarkers in Resistant Migraine: A Real-Life Study with Erenumab, Fremanezumab, and Galcanezumab
por: De Luca, Ciro, et al.
Publicado: (2021)

Erenumab and Possible CGRP Effect on Chronotype in Chronic Migraine: A Real-Life Study of 12 Months Treatment
por: Pilati, Laura, et al.
Publicado: (2023)

Sumatriptan and dihydroergotamine in proximal and distal human isolated coronary arteries
por: Labruijere, S, et al.
Publicado: (2013)

Characterization of the trigeminovascular actions of several adenosine A(2A) receptor antagonists in an in vivo rat model of migraine
por: Haanes, Kristian A., et al.
Publicado: (2018)

Capsaicin-induced CGRP-mediated vasodilatation of the human skin: influence of gender, female hormones and migraine
por: Vermeersch, SGG, et al.
Publicado: (2013)

The role of erenumab in the treatment of migraine
por: Andreou, Anna P., et al.
Publicado: (2020)

Efficacy and Tolerability of Erenumab for Prevention of Episodic Migraine in India
por: Chowdhury, Debashish, et al.
Publicado: (2022)

CGRP and migraine
por: Cauchi, M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_el13ebbgf4qsu1jc6p1d6o9tkr